Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Canaccord Genuity cuts Jet2 target price but sticks with 'buy'

(Sharecast News) - Canaccord Genuity has lowered its target price for Jet2 but kept a 'buy' rating on the stock, saying the holidays group has the potential to grow its market share while it maintains a strong balance sheet. Results from the travel operator on Wednesday delivered results in line with expectations, with adjusted profit before tax falling 6% to £544.6m over the year to 31 March on the back of weaker margins, but revenues rising 4% to a record £7.48bn.

Canaccord Genuity said it has raised its FY27 projections due to a better cost outlook and strong load factor (percentage of available seating capacity filled).

"We project FY28 to see a return to nearer to historical PBT margins, but now slightly dampen these due to the economic, fiscal and consumer risks from an untested potential new UK Prime Minister," said analyst Damian Brewer.

Nevertheless, the broker said it sees "strong share growth potential" as it penetrates the southern half of the UK.

Meanwhile, following Jet2's announcement of a £250m share buyback for FY27, Brewer said the company could have even more capital potentially available to allocate in the future, given its strong cash generation and headroom with current debt facilities.

The broker cut its target price for the stock from 1,900p to 1,750p, indicating further upside despite Wednesday's 11.4% jump to 1,510.05p by 1405 BST.

Share this article

Related Sharecast Articles

ConocoPhillips to buy 42% stake in BP Iraq oil fields
(Sharecast News) - BP said on Friday that it has agreed terms for ConocoPhillips to buy a 42% interest in BP Energy Company of Kirkuk (BP ECKL).
GSK shares fall as cough drug development axed
(Sharecast News) - Shares in GSK fell sharply on Friday after the pharma titan announced it was stopping the development of a refractory chronic cough drug after unsuccessful results late-stage clinical trial.
Deutsche Bank downgrades Rotork after ABB takeover
(Sharecast News) - Deutsche Bank downgraded Rotork on Friday to 'hold' from 'buy' and lifted the price target to 503p from 400p after it agreed to be bought by Swiss engineering firm ABB in a £4.1bn deal.
Wise Q1 revenues rise as customer numbers grow
(Sharecast News) - Wise reported an increase in first-quarter revenue on Friday as customer numbers at the money transfer firm rose.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.